Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
alcohol)
By combining agents with different mechanisms, prescribers can address the same problem from multiple angles simultaneously and keep the dose of each agent lower
Real-World Use Cases of GLP-1 Analogues Source: Polaris Market Research Analysis Source: Polaris Market Research Analysis GLP-1 Analogues Market Value Chain Analysis The value chain of GLP-1 analogues market begins with the drug development process, which involves drug discovery and preclinical testing
For some patients, staying longer at a lower dose may be more appropriate than pushing upward quickly
The combination of AZD6234 with other incretin-based agents, such as the GLP-1/glucagon dual agonist AZD9550, is also being investigated in a phase 1 trial, with the planning for a phase 2 trial underway
US$ 25.98
US$ 28.41
US$ 22.26
US$ 28.16
